A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin

NCT01756495 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Losmapimod
DRUG: Moxifloxacin
DRUG: Losmapimod matched Placebo
DRUG: Moxifloxacin Placebo

Sponsor

GlaxoSmithKline